MIRA (STOCKS)
MIRA Pharmaceuticals, Inc. Common Stock
$0.789800
+0.051100 (+6.92%)
Prev close: $0.738700
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Other
- CEO
- Erez Aminov
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $38.21M
- Employees
- 5
- P/E (TTM)
- -0.51
- P/B (TTM)
- 3.32
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Nonoperating Income/Loss | -$17.47K |
| Operating Expenses | $9.79M |
| Research and Development | $1.93M |
| Other Operating Expenses | $7.86M |
| Income/Loss From Continuing Operations After Tax | -$9.81M |
| Income/Loss From Continuing Operations Before Tax | -$9.81M |
| Interest Income/Expense After Provision For Losses | $122.40K |
| Interest Income/Expense Operating, Net | $122.40K |
| Net Income/Loss | -$9.81M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$9.81M |
| Net Income/Loss Available To Common Stockholders, Basic | -$31.37M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $21.56M |
| Preferred Stock Dividends And Other Adjustments | $21.56M |
| Provision For Loan, Lease, And Other Losses | $0.00 |
| Basic Earnings Per Share | -$1.20 |
| Diluted Earnings Per Share | -$1.20 |
| Basic Average Shares | 83,912,497 |
| Assets | $9.46M |
| Current Assets | $9.43M |
| Prepaid Expenses | $21.75K |
| Other Current Assets | $9.41M |
| Noncurrent Assets | $35.44K |
| Liabilities | $114.76K |
| Current Liabilities | $114.76K |
| Accounts Payable | $34.01K |
| Other Current Liabilities | $80.75K |
| Noncurrent Liabilities | $0.00 |
| Equity | $9.35M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $9.35M |
| Liabilities And Equity | $9.46M |
| Net Cash Flow From Operating Activities | -$4.23M |
| Net Cash Flow From Operating Activities, Continuing | -$4.23M |
| Net Cash Flow From Investing Activities | -$3.61M |
| Net Cash Flow From Investing Activities, Continuing | -$3.61M |
| Net Cash Flow From Financing Activities | $7.84M |
| Net Cash Flow From Financing Activities, Continuing | $7.84M |
| Net Cash Flow | $0.00 |
| Net Cash Flow, Continuing | $0.00 |
| Comprehensive Income/Loss | -$9.81M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$9.81M |
| Other Comprehensive Income/Loss | $0.00 |